Trial intelligence / Profile preview

Local vs intraperitoneal bupivacaine for pain after laparoscopic cholecystectomy

IRCT20230526058293N1Phase 3Completed

Sponsor
Islamic Azad University
Start
Jun 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of bupivacaine in postoperative pain (2 arms), sponsored by Islamic Azad University. Primary endpoint: Postoperative pain intensity. Started Jun 2023; status: completed.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on IRCT20230526058293N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20230526058293N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call